Melanocortin Peptides Research Guide: MT-1, MT-2, PT-141 and the Alpha-MSH System

The melanocortin system is one of the most pharmacologically rich receptor families in biology. Five receptor subtypes (MC1R-MC5R), two endogenous agonist families (POMC-derived peptides including alpha-MSH and ACTH), and two endogenous antagonists (agouti protein and AgRP) create a complex regulatory network spanning pigmentation, energy homeostasis, inflammation, sexual function, and exocrine secretion.

Signal Labs supplies three research tools for melanocortin pharmacology: MT-1 (MC1R-selective), MT-2 (pan-MCR), and PT-141/Bremelanotide (MC3R/MC4R-focused, FDA approved). This guide provides a complete comparison to help researchers select the appropriate compound for their experimental context.

The Alpha-MSH System: POMC-Derived Peptides

All melanocortin agonists — both endogenous and synthetic — are structurally related to the His-Phe-Arg-Trp tetrapeptide core that represents the minimal MCR binding pharmacophore. This core is embedded in:

ACTH (39 amino acids): The full-length POMC-derived peptide that activates all MCRs and is also the precursor to alpha-MSH.

Alpha-MSH (13 amino acids, Ac-SYSMEHFRWGKPV-NH2): The primary melanocortin agonist for skin pigmentation biology, derived from ACTH by tissue-specific proteolytic processing in the pituitary and arcuate nucleus.

Gamma-MSH: An N-terminal POMC fragment that preferentially activates MC3R.

Beta-MSH: Activates MC3R and MC4R, connecting melanocortin biology to energy balance.

The two endogenous antagonists — agouti protein (MC1R/MC2R antagonist in skin) and AgRP (MC3R/MC4R antagonist in hypothalamus) — create the competitive agonist/antagonist balance that regulates pigmentation and energy homeostasis respectively.

Receptor Subtype Biology and Research Tool Selection

MC1R research (use MT-1).
MC1R is expressed on melanocytes (pigmentation), macrophages, dendritic cells, and NK cells. MC1R activation drives cAMP/PKA/CREB/MITF transcriptional cascade upregulating tyrosinase and eumelanin synthesis. MC1R is also an anti-inflammatory receptor in immune cells, driving IL-10 production and suppressing NFkB activity. MT-1 is the preferred research tool for MC1R research due to its high MC1R selectivity and linear structure (enabling comparison with modifications that improve or alter selectivity).

MC4R research (use PT-141).
MC4R is expressed predominantly in the CNS — hypothalamic PVN, DMH, arcuate nucleus, brainstem — and is the primary melanocortin receptor for energy homeostasis and sexual function research. MC4R null mice are obese, establishing MC4R as a critical regulator of body weight. PT-141's FDA approval as Vyleesi establishes it as the validated MC4R CNS research tool with extensive published pharmacology. Its better CNS penetration versus MT-1 or MT-2 makes it the preferred choice for CNS-focused MCR research.

Pan-MCR research (use MT-2).
When research requires activation of the full range of MCR subtypes — or when comparative pharmacology across all five receptors is the research goal — MT-2's cyclic structure and pan-MCR activity makes it the appropriate choice. MT-2 also serves as the historical reference compound from which PT-141 was derived, making it essential for comparative structure-activity relationship studies.

MC3R/MC5R research.
MC3R (hypothalamus, adipose, macrophages) and MC5R (exocrine glands, immune cells) are less specifically targetable with the compounds above. MT-2 provides the broadest MCR coverage including MC3R and MC5R alongside MC1R and MC4R.

Published Research References

For laboratory and analytical research purposes only. Not for human or veterinary use.

MT-1 (Melanotan I) | MT-2 (Melanotan II) | PT-141 (Bremelanotide) | KPV

POMC Processing: Multiple Active Peptides from One Gene

The POMC gene encodes a large precursor protein (266 amino acids) that is processed by tissue-specific prohormone convertases (PC1/3, PC2) into multiple bioactive peptides depending on cell type:

Pituitary corticotrophs (PC1/3-expressing): POMC → ACTH (39aa) + beta-lipotropin (beta-LPH). ACTH is the primary product activating adrenocortical MC2R.

Pituitary melanotrophs and hypothalamic arcuate neurons (PC1/3 + PC2): POMC → alpha-MSH + CLIP + beta-LPH → beta-MSH + beta-endorphin. Alpha-MSH (positions 1-13 of ACTH) is the primary melanocortin agonist for MC1R, MC3R, MC4R, and MC5R.

Skin keratinocytes (PC1/3): UV exposure drives local POMC expression and processing to ACTH and alpha-MSH — the "UV → POMC → alpha-MSH → MC1R → melanogenesis" axis operates locally in skin, independent of pituitary signalling.

MT-1 (Afamelanotide) is an alpha-MSH analogue that mimics the pituitary/keratinocyte-produced alpha-MSH. MT-2 and PT-141 are cyclic alpha-MSH analogues optimised for receptor affinity and CNS penetration. Understanding their relationship to endogenous POMC processing is essential for interpreting research results in the correct biological context.

AgRP and Agouti: The Endogenous Antagonist System

The melanocortin system is unique in having two endogenous antagonists:

AgRP (Agouti-related protein): Expressed by arcuate nucleus neurons and acts as an inverse agonist/antagonist at MC3R and MC4R. Elevated in energy deficit states. AgRP-expressing neurons are the primary orexigenic neurons of the hypothalamus, opposing the anorexigenic POMC neuron population.

Agouti protein: Expressed in hair follicle dermal papilla cells. Acts as a paracrine antagonist at MC1R in melanocytes, shifting melanin synthesis from eumelanin (brown/black) to pheomelanin (yellow/red). Coat colour genetics in mice — yellow Avy mice overexpress agouti, shifting coat colour and causing obesity through MC4R antagonism.

Research using MT-2 and PT-141 in the presence of AgRP provides a tool for examining competitive antagonism at MC3R and MC4R — relevant for research on the endogenous melanocortin tone that these synthetic agonists override.

Frequently Asked Questions

Why is there a difference between MT-1 research applications and MT-2 research applications if both activate melanocortin receptors?
The key difference is receptor selectivity: MT-1 activates primarily MC1R, making it the tool of choice for melanogenesis, photoprotection, and MC1R-mediated immunomodulation research. MT-2 activates MC1R, MC3R, MC4R, and MC5R — making it appropriate for research requiring pan-MCR stimulation or for comparing MC4R-mediated CNS effects with MC1R-mediated peripheral effects in the same experiment. Using both MT-1 (MC1R selective) and MT-2 (pan-MCR) in parallel with MC4R-selective antagonists allows researchers to dissect which MCR subtype is responsible for any given biological effect.

What is the connection between melanocortin research and inflammation biology?
MC1R, MC3R, and MC5R are all expressed on immune cells (macrophages, dendritic cells, T cells) where their activation through cAMP/PKA reduces NFkB-driven inflammatory cytokine production. KPV (Lys-Pro-Val, C-terminal alpha-MSH fragment) has been studied specifically for this anti-inflammatory melanocortin signalling. The immune cell melanocortin system represents an endogenous anti-inflammatory pathway — when POMC-derived alpha-MSH reaches immune cells during stress or infection, MC1R/MC3R activation provides a brake on excessive inflammation. MT-1 research examining MC1R in macrophage and dendritic cell models contributes to this inflammation biology, connecting melanocortin pharmacology to the broader immunology research landscape.

Browse all Signal Labs research peptides | Peptide storage guide | Reconstitution guide

Melanocortin Research Tool Summary and Selection Guide

For researchers selecting the appropriate melanocortin tool compound, this summary provides a concise decision framework based on receptor target and experimental objective:

For experiments requiring mechanistic attribution to specific receptor subtypes, complement tool compound selection with receptor-selective antagonists: HS-024 (MC4R-selective), SHU9119 (MC3R/MC4R), agouti protein (MC1R/MC2R), and AGRP (MC3R/MC4R inverse agonist).

All three compounds — MT-1, MT-2, and PT-141 — are available individually from Signal Labs at greater than or equal to 98% HPLC-verified purity for research applications.